CoChat

An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis

Ormarsdóttir, S., Mallmin, H., Naessén, T., Petrén‐Mallmin, M., Broomé, U., Hultcrantz, R., Lööf, L. · 2004 · Journal of Internal Medicine
Cited by 55

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

: Objectives. The prevalence of osteoporosis amongst patients with primary biliary cirrhosis (PBC) is high and may be a serious clinical problem. Hormone replacement therapy (HRT) is effective in preventing bone loss but has not been evaluated in randomized trials in PBC. The primary aim was to study the effect of transdermal HRT in combination with daily vitamin D and calcium supplementation on bone loss compared with vitamin D and calcium supplementation only in postmenopausal women with PBC. The secondary aim was to study the safety of transdermal HRT. Subjects/interventions. Eighteen females with PBC were randomized to receive 2 years therapy with either (i) transdermal oestradiol 50 μ g 24 h−1 two times per week + medroxyprogesterone 2.5 mg day−1 + alfacalcidol 0.25 μ g day−1 and calcium 1 g day−1 or (ii) alfacalcidol 0.25 μ g day−1 and calcium 1 g day−1. Dual‐energy X‐ray absorptiometry for measurement of bone mineral density (BMD) and sampling of blood and serum for measurements of biochemical markers of liver function was performed before, during and at the end of treatment. Results. BMD increased significantly at the lumbar spine (P < 0.05) and the femoral neck (P < 0.05) in the HRT group whereas no significant change was found in the control group. One oestrogen‐treated patient was excluded after 1 year because of deteriorating, but reversible, aminotransferases. Dropout frequency because of nonliver‐related causes was higher in the HRT group. Otherwise, no difference with respect to adverse liver reactions was found between the groups. Conclusion. Transdermal HRT increases BMD in PBC patients with few severe side effects related to the liver.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2796.2004.01342.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 55

Metadata

Authors
Ormarsdóttir, S., Mallmin, H., Naessén, T., Petrén‐Mallmin, M., Broomé, U., Hultcrantz, R., & Lööf, L.
Venue
Journal of Internal Medicine
Publisher
Wiley
Published
2004-06-03
Volume
256
Issue
1
Pages
63-69
ISSN
  • 0954-6820 (ISSN-L)
  • 1365-2796
OpenAlex
W2131882991
Cited by
55
References
5
FWCI
4.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis. https://app.cochat.ai/papers/10.1111/j.1365-2796.2004.01342.x
The paper
Ormarsdóttir, S., Mallmin, H., Naessén, T., Petrén‐Mallmin, M., Broomé, U., Hultcrantz, R., & Lööf, L. (2004). An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis. Journal of Internal Medicine. https://doi.org/10.1111/j.1365-2796.2004.01342.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.